Multiple layer filamentary devices for treatment of vascular defects

US9918720B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9918720-B2
Application numberUS-201213439754-A
CountryUS
Kind codeB2
Filing dateApr 4, 2012
Priority dateNov 5, 2009
Publication dateMar 20, 2018
Grant dateMar 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices and methods for treatment of a patient's vasculature with some embodiments configured for delivery with a microcatheter for treatment of the cerebral vasculature of a patient. Some embodiments may include a permeable shell and inner structure configured to occlude blood flow therethrough.

First claim

Opening claim text (preview).

What is claimed is: 1. A device for implantation within a vascular defect or aneurysm, comprising: a self-expanding resilient outer layer including: a proximal end, a distal end, a longitudinal axis, a plurality of elongate filaments disposed in a woven structure, the outer layer being movable to a radially constrained elongated state configured for delivery within a microcatheter with the elongate filaments extending longitudinally from the proximal end to the distal end radially adjacent each other along a length of the filaments, and the outer layer being biased to an expanded relaxed state with a longitudinally shortened configuration relative to the radially constrained state with the elongate filaments being bundled and secured relative to each other at the distal end of the outer layer and the elongate filaments being bundled and secured relative to each other at the proximal end of the outer layer, the woven filaments forming a smooth path radially expanded from the longitudinal axis between the proximal end and distal end including a plurality of openings in the outer layer formed between the woven elongate filaments, the outer layer having a distal-most surface end defining a distal contour; and an inner layer forming an enclosed volume which is disposed within a cavity of the outer layer, the inner layer including a plurality of woven filamentary members which are secured relative to each other at a free distal end of the inner layer and which are secured relative to each other and the proximal end of the outer layer at a proximal end of the inner layer with the free distal end of the inner layer being unsecured to the outer layer such that the inner layer forms a separate lobe from the outer layer and the free distal end of the inner layer can longitudinally shorten independently of the outer layer, the inner layer having a distal-most surface defining a distal contour, the distal contour of the inner layer being the same as the distal contour of the outer layer at least in the expanded relaxed state, an internal gap being established between the distal-most surface of the outer layer and the distal-most surface of the inner layer in the expanded relaxed state, the internal gap being between 5% and 40% of a total longitudinal height of the device measured along a longitudinal axis of the device. 2. The device of claim 1 wherein the largest of the openings in the resilient outer layer formed between the woven filaments are configured to reduce blood flow velocity through the openings to a velocity below a thrombotic threshold velocity. 3. The device of claim 1 wherein the largest of the openings in the resilient outer layer formed between the woven filaments are configured to reduce blood flow velocity through the openings to a velocity that achieves hemostasis in the vascular defect or aneurysm. 4. The device of claim 1 wherein filaments of the resilient outer layer comprise a transverse dimension or diameter that is about 0.001 inches to about 0.004 inches. 5. The device of claim 1 wherein filaments of the inner layer comprise a transverse dimension or diameter that is less than about 0.001 inches. 6. The device of claim 1 wherein the resilient outer layer comprises about 70 filaments to about 300 filaments extending from the proximal end of the outer layer to the distal end of the outer layer. 7. The device of claim 1 wherein the inner layer comprises about 70 filaments to about 300 filaments extending from the proximal end of the inner layer to the distal end of the inner layer. 8. The device of claim 1 wherein a major transverse dimension of the resilient outer layer in a relaxed expanded state is about 4 mm to about 30 mm. 9. The device of claim 1 wherein the filaments of the outer layer comprise a first set of filaments, each filament of the first set having a first transverse dimension and a second set of filaments, each filament of the second set having a second transverse dimension different from the first transverse dimension. 10. The device of claim 1 wherein the filamentary members of the inner layer comprise a first set of filaments, each filament of the first set having a first transverse dimension and a second set of filaments, each filament of the second set having a second transverse dimension different from the first transverse dimension. 11. The device of claim 1 , wherein the internal gap is about 8% to about 35% of the longitudinal height of the device.

Assignees

Inventors

Classifications

  • for positioning in conjunction with a stent · CPC title

  • having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526) · CPC title

  • Methods of manufacturing · CPC title

  • Occluding by internal devices, e.g. balloons or releasable wires (plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20) · CPC title

  • within an aneurysm · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9918720B2 cover?
Devices and methods for treatment of a patient's vasculature with some embodiments configured for delivery with a microcatheter for treatment of the cerebral vasculature of a patient. Some embodiments may include a permeable shell and inner structure configured to occlude blood flow therethrough.
Who is the assignee on this patent?
Marchand Philippe, Cox Brian J, Rosenbluth Robert F, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61B17/12113. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).